Research Article
Risk Assessment of Dyslipidemias, Hyperglycemia, Hyperuricemia, and Hypertension Utilizing Self-Reported Body Silhouettes
Table 2
Biochemical or anthropometric markers according to the type of body silhouette.
| | Biochemical or anthropometric markers | Self-reported body silhouette | Rho S | | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 |
| Male | BMI (kg/m2) | 20.5 [19.2–22.7] | 22.5 [20.6–24.1] | 23.5 [21.8–25.4] | 24.1 [22.7–26.3] | 25.4 [23.8–27.2] | 26.5 [24.7–28.3] | 27.9 [26.2–29.8] | 30.4 [28.4–33.1] | 34.7 [29.4–42.3] | 0.635 | <0.001 | Triglycerides (mg/dL) | 114 [87–154] | 111 [83–175] | 125.5 [87.3–201.8] | 143 [93–200.5] | 172.5 [115.3–256.5] | 169 [115–225.5] | 175 [125–257.3] | 195 [138–270] | 183 [123–255] | 0.241 | <0.001 | Total cholesterol (mg/dL) | 176.8 [152–210] | 173 [155.7–196.8] | 185.5 [159–212.9] | 184 [160.5–209 0.7] | 192.6 [167–217] | 194 [170.8–218.2] | 196 [173–222.1] | 198.4 [171.5–226.8] | 189 [163.5–239.9] | 0.138 | <0.001 | LDL cholesterol (mg/dL) | 105 [84–122.5] | 95 [80–121] | 109.5 [86–139.8] | 114 [88–134] | 115 [93–136] | 122 [96.8–142] | 119 [93–141] | 118 [94–141.3] | 127 [96–149] | 0.113 | <0.001 | HDL cholesterol (mg/dL) | 44.5 [35.5–51] | 40 [33–46] | 39 [33–45] | 38 [33–42] | 37 [31.5–43] | 37 [31–42] | 36 [32–41] | 36 [30.3–40] | 36 [28.5–40.5] | −0.140 | <0.001 | Glucose (mg/dL) | 86 [80–92] | 89 [81–95] | 89 [84–96] | 90 [83.5–97] | 91 [85–98] | 91 [85–98] | 36 [87–102] | 36 [89–104] | 97 [89–106.5] | 0.210 | <0.001 | Uric acid (mg/dL) | 5.2 [3.8–6.1] | 5.3 [4.6–6.3] | 5.4 [4.6–6.2] | 5.7 [4.8–6.5] | 5.7 [4.9–6.5] | 5.9 [5.1–6.8] | 5.9 [5.1–6.8] | 6.3 [5.4–7.3] | 6.4 [5.6–7.8] | 0.210 | <0.001 | Diastolic blood pressure (mmHg) | 71 [64–76.8] | 70 [63–75] | 73 [67–80] | 73 [67.7–80.7] | 73 [67–81] | 75 [67–82] | 76 [68.9–83] | 76 [69–84] | 81 [70–86.7] | 0.140 | <0.001 | Systolic blood pressure (mmHg) | 71 [112.3–123.8] | 116 [108–127] | 121 [112–130.8] | 121.2 [114–131.3] | 122 [115–130] | 123 [114.5–132] | [116.2 124 133] | 126 [119–135.6] | 132 [125–138] | 0.167 | <0.001 |
| Female | BMI (kg/m2) | 19.4 [18.2–20.5] | 20.5 [19.2–21.7] | 22.4 [20.9–23.7] | 25 [23.4–26.6] | 25.8 [23.9–27.9] | 26.7 [24.9–28.6] | 29.7 [27.6–32] | 33.1 [30.6–35.5] | 37.9 [34.5–42.2] | 0.742 | <0.001 | Triglycerides (mg/dL) | 85 [61–128.5] | 84 [66–121] | 96 [73–136] | 116 [85–160] | 125 [87–174] | 129 [93.8–182] | 140 [106–189] | 152 [114–203.3] | 150 [114.8–183.3] | 0.299 | <0.001 | Total cholesterol (mg/dL) | 184.3 [150.7–200.4] | 173.2 [154.7–194.6] | 177.1 [155–204.9] | 184 [163–208.6] | 185.3 [165.4–219] | 191 [168.2–220] | 195.3 [172.4–223] | 193.4 [169–214.7] | 197.3 [166.8–223.3] | 0.172 | <0.001 | LDL cholesterol (mg/dL) | 101 [67–127.5] | 99.5 [78.3–124.5] | 105 [81–131] | 111 [89–136] | 113 [88–142] | 120 [93–144.8] | 124 [100–148] | 121 [96–143] | 126 [94–148.5] | 0.181 | <0.001 | HDL cholesterol (mg/dL) | 41 [34.8–59.3] | 45 [36–50] | 42 [34–50] | 39 [33–47] | 41 [34–47] | 38 [32–45] | 37 [32–44] | 37 [31–43] | 39 [34.8–45.3] | −0.153 | <0.001 | Glucose (mg/dL) | 81.5 [75.8–89.3] | 83 [77–89] | 84 [79–90] | 86 [81–92] | 87 [80.3–93] | 88 [82–95] | 91 [85–99] | 96 [88–103] | 93 [85.8–108] | 0.298 | <0.001 | Uric acid (mg/dL) | 3.8 [3.2–4.3] | 3.6 [2.9–4.3] | 3.9 [3.1–4.6] | 4.1 [3.4–4.9] | 3.4 [4.2–5.1] | 4.5 [3.7–5.2] | 4.7 [3.9–5.5] | 5 [4.3–6] | 5 [4.1–6.3] | 0.303 | <0.001 | Diastolic blood pressure (mmHg) | 69 [60–70.8] | 68 [60–74] | 68 [61–74] | 69.7 [62–75.9] | 71 [65–78] | 70 [64–77.7] | 73 [66–79] | 74 [68–80] | 76 [68–82.5] | 0.210 | <0.001 | Systolic blood pressure (mmHg) | 110 [104.5–119] | 110 [102.3–116.8] | 109.5 [103–115] | 110 [105–120] | 113 [106–121.7] | 113 [106–121.3] | 117 [110–126] | 119 [110–129] | 120 [111.5–131] | 0.254 | <0.001 |
|
|
Median (interquartile range 25th–75th); Rho S, rho spearman.
|